#PrecisionMedicine company, empowering #oncologists with personalized treatment options for patients with #cancer
San Diego, CA
- Tweets 888
- Following 2,868
- Followers 1,325
- Likes 794
Pinned Tweet
🚀 Our landmark study in npj Genomic Medicine shows better outcomes when cancer biology is well-matched: survival doubled (OS 18.7 vs 9.0 mo; HR 0.54, P=0.003) in multivariate analysis validating @CureMatch Score👇Link in comments
1
1
9
1,001
🚀 Our landmark study in npj Genomic Medicine shows better outcomes when cancer biology is well-matched: survival doubled (OS 18.7 vs 9.0 mo; HR 0.54, P=0.003) in multivariate analysis validating @CureMatch Score👇Link in comments
1
1
9
1,001
📊 Read the full open-access study here: nature.com/articles/s41525-0…
1
131
The hard work put in every day, by so many to deliver better clinical decision support, with our amazing cofounder @Dr_R_Kurzrock blazing a path to prolong lives and save lives. This is TRUE precision medicine. Each cancer is molecularly unique.
linkedin.com/posts/precision…
1
112
CureMatch retweeted
So incredibly proud of our @CureMatch team! The hard work put in every day, by so many to deliver better clinical decision support, with our amazing cofounder @Dr_R_Kurzrock blazing a path to prolong lives and save lives.
linkedin.com/posts/precision…
2
2
2,943
CureMatch retweeted
Bringing experts together from across the nation to help rare cancer patients
Have you ever wondered what takes place in a TCF-001 TRACK Virtual #MolecularTumorBoard meeting?
Watch to learn how biomarker testing and multi-disciplinary expertise come together to uncover treatment options for difficult-to-treat #RareCancers
targetcancer.short.gy/RCTT-2…
1
4
14
1,951
CureMatch retweeted
We've officially announced the next evolution of #cmAngio®. Building on FDA-cleared BAC detection, cmAngio now detects, quantifies & contextualizes Breast Arterial Calcification (BAC). New: BAC quantification, Age-Based Percentile & Prevalence.
einpresswire.com/article/934…
2
1
84
What if cancer treatment could be lethal to the tumor—but not the patient?
Clinical and multi-omics data now reveal each cancer’s unique hallmarks and drivers.
2
74
At CureMatch, we transform complex molecular profiles into ranked, personalized combination options so oncologists can deliver more precise care.
Precision medicine isn’t the future.
It’s happening now.
#PrecisionOncology #MultiOmics #PersonalizedMedicine #CureMatch
29
This insight enables highly targeted therapies that attack the disease while sparing healthy tissue—improving efficacy and reducing harm.
31
Pancreatic cancer remains one of the deadliest malignancies. Uncovering its molecular drivers is critical.
CureMatch helps ranks, genomically matched combination therapies to help oncologists target them. #PancreaticCancer #PrecisionMedicine
1
68
Rare cancers foreshadow the future of precision oncology. As molecular characterization becomes increasingly comprehensive, classification based on tissue of origin or single biomarkers gives way to recognition that each tumor possesses a unique and complex molecular identity.
1
63
“The N-of-1 paradigm reframes cancer as requiring customized therapeutic solutions. Future advances will depend not only on new drugs but also on validating sophisticated matching algorithms capable of delivering truly personalized cancer care.” From our cofounder @Dr_R_Kurzrock
18
CureMatch retweeted
One gene/one target has a ceiling in complex cancers. Either treat earlier before complex evolution or give biomarker matched combinations or both
Pleasure to work with @VivekSubbiah on this concept
⭐️Pleased to share our paper 👉🏼Beyond one gene, one target: Next-generation precision oncology: Trends in Cancer @trendscancer @CellCellPress @CellPressNews @OncoAlert @Dr_R_Kurzrock
cell.com/trends/cancer/fullt…
2
3
7
1,239
CureMatch retweeted
On days like today I think about the future and strategize.
Following progress over decades I am excited to continue shaping the future of precision oncology clinical practice with research innovations, technology breakthroughs, education and training to help patients in Rhode Island and globally.
It is a powerful motivator to see discoveries in my lab over 3 decades culminate in FDA approval of ONC201/dordaviprone less than a year ago in 2025 to treat these aggressive H3K27M-mutated diffuse gliomas.
This unique and amazing precision oncology story is only the beginning of what has to happen for patients building on lessons learned. There are many novel drugs and drug combinations waiting to be translated for brain and other tumor types.
Technologies and AI are still fairly primitive but important progress is being made.
Looking forward to the 2026 WIN Symposium on October 2-3, 2026 at the Rhode Island Convention Center in Providence. It should be a great event with the world-class faculty in attendance. Register for the event at mcigroup-winsymposium2026.ev…
@BrownUnivHealth @WIN_Consortium @SWOG @AmericanCancer @bcarneiro7 @LiangChengMD @carisls @Dr_R_Kurzrock @JazzPharma @AshleySumrall @LiaTsimberidou @SewantiLimaye @LussierY @DrRoyHerbst @jrgralow @BrownUniversity @BrownOncology @TempusAI @CureMatch @JiaJennyLiu @billdahutmd @charlesbalchmd @ASCO @VivekSubbiah @SenduraiMani @SeanLawler20
3
6
21
40,836
Pancreatic ductal adenocarcinoma (PDAC) accounts for 90% of pancreatic cancers & carries a poor prognosis. Chemotherapy remains the mainstay treatment. CureMatch helps oncologists navigate these complex cases with ranked, molecularly matched treatment options. #PancreaticCancer
59
We have launched this campaign through our amazing non-profit partner @MusicBeatCancer!
All donations tax deductible…The link allows anywhere from $25 to $25,000.
We are looking to cover 500 cancer patients with financial challenges with a @CureMatch report.
2
1
53